Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study
Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study
Not yet recruiting · NCT07523867 · Registry updated 2026-05-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study | Chronic Disease, Diabetes Complications, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hyperkalemia, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Water-Electrolyte Imbalance, cardio-renal syndrome, cardiovascular disorder, chronic renal failure syndrome, diabetes mellitus, diabetic kidney disease, endocrine system disorder, heart disorder, heart failure, kidney disorder, kidney failure, metabolic disease, urinary system disorder | Not yet recruiting | Phase 4 | 2026-05-13 | NCT07523867 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hospital de Messejana Dr. Carlos Alberto Studart Gomes | 1 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||